Modelling medication adherence patterns for patients with serious mental and physical illnesses

Please check out my recent paper titled “Medication Adherence Patterns Among Patients with Multiple Serious Mental and Physical Illnesses” with co-authors Joanna P. MacEwan, Alison R. Silverstein, Darius N. Lakdawalla, Ainslie Hatch and Felicia M. Forma in Advances in Health.   This study is unique because it looks at medication adherence patterns among patients with…

Access to credible information on schizophrenia patients’ medication adherence by prescribers can change their treatment strategies

Below is the abstract for my most recent publication titled “Access to credible information on schizophrenia patients’ medication adherence by prescribers can change their treatment strategies: evidence from an online survey of providers“.  It is work with Suepattra G May, Anshu Shrestha, Charles Ruetsch, Nicole Gerlanc, Felicia Forma, Ainslie Hatch, Darius N Lakdawalla, and Jean-Pierre Lindenmayer.…

Patterns of Adherence to Atypical Antipsychotics

A study titled “Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia” was just published in the November edition of JMCP.  This is work with co-authors Joanna P. MacEwan, Felicia M. Forma, Jason Shafrin, Ainslie Hatch, Darius N. Lakdawalla, Jean-Pierre Lindenmayer. The abstract is below.  Go check it out! BACKGROUND: Poor medication adherence…

The value of adherence information

A study titled “Estimating the Value of New Technologies That Provide More Accurate Drug Adherence Information to Providers for Their Patients with Schizophrenia” was just published in the November edition of JMCP.  This is work with co-authors Taylor T. Schwartz, Darius N. Lakdawalla, and Felicia M. Forma.  The abstract is below.  Go check it out!  …

Does adherence information affect physician decisions?

According to a recent study of patients with hypertension, the answer is yes. The study by Kronish et al. (2016) used a cluster randomized trial design made up of 24 providers and 100 patients.  Half of the providers were randomized to receive received a report summarizing electronically measured patient adherence to their blood pressure regimen as well as and recommended clinical to…

Can physicians affect medication adherence?

According to a recent study by Koulayev, Simeonova, and Skipper (2016) using data from Denmark, the answer is ‘yes’. Non-compliance with medication therapy remains an unsolved and expensive problem for healthcare systems around the world, yet we know little about the factors that affect a patient’s decision to follow treatment recommendations. In particular, there is…

Do physicians know whether patients are adherent?

Doctors have access to life saving medication for a number of illnesses.  However, the medication only works when patients take the drugs.  Are physicians able to determine which patients are adherent to their medication?  According to an article in JAMA Cardiology, the answer is ‘no’ for cardiology patients. Forty (61%) patients reported rarely or never…

The Cost of Adherence Mismeasurement: A Claims-Based Analysis

If you are attending AMCP Nexus in October, I am a co-author on a poster presentation titled “The Cost of Adherence Mismeasurement: A Claims-Based Analysis” co-authored with Felicia Forma, Ethan Scherer, Ainslie Hatch and Darius Lakdawalla.  The presentation abstract is below and here. BACKGROUND: Payers often wish to measure how adherence to prescription drugs affects downstream…

AMCP Nexus Poster: Adherence Patterns for Oral Atypical Antipsychotics in Patients Diagnosed with Schizophrenia

If you are attending AMCP Nexus in October, I am a co-author on a poster presentation titled “Adherence Patterns for Oral Atypical Antipsychotics in Patients Diagnosed with Schizophrenia” co-authored with Joanna MacEwan, Felicia Forma, Ainslie Hatch and Darius Lakdawalla.  The presentation abstract is below and here.   BACKGROUND: Many payers rely on claims-based metrics—such as those…